Jazz First Patient Enrolled in P-III (IMforte) Trial of Zepzelca (lurbinectedin) + Tecentriq for Extensive-Stage Small Cell Lung Cancer
Shots: The first patient has enrolled in a P-III (IMforte) trial...
SpringWorks Completes an Enrollment of Mirdametinib in P-IIb ReNeu Trial for the Treatment of NF1-Associated Plexiform Neurofibromas
Shots: The company has completed enrolment in the P-IIb ReNeu trial to evaluate mi...
The US FDA Placed a Clinical Hold on the Ocugen’s IND Application for Covaxin (BBV152) to Treat COVID-19
Shots: The US FDA has issued a clinical hold on the Ocugen’s IND application...
Clover Initiates P-II Trial of COVID-19 Vaccine as Heterologous Booster for the Treatment of COVID-19
Shots: The company initiates a P-II trial in 2 stages to evaluate 3 formulations,...
Merck and Ridgeback Provide Update on MOVe-OUT Study of Molnupiravir for the Treatment of COVID-19
Shots: The MOVe-OUT study evaluates molnupiravir (MK-4482, EIDD-2801) vs PBO in 14...
Selecta Biosciences’s Reports the US FDA's Clinical Hold on the P-I/II Clinical Trial of SEL-302 for the Treatment of Methylmalonic Acidemia
Shots: The US FDA has placed a clinical hold on the P-I/II clinical trial of SEL-3...
